Why the study?
Are inflammatory cell type-specific parameters, specifically neutrophil activation markers, sustained over a longer period in children with Kawasaki disease compared to controls?
Are inflammatory cell type-specific parameters, specifically neutrophil activation markers, sustained over a longer period in children with Kawasaki disease compared to controls?
Neutrophil activation in Kawasaki disease persists for at least three months, longer than previously assumed, which may relate to coronary artery lesion formation.
Answers are grounded in this paper and cite their sources.
Sustained neutrophil activation may support extended monitoring in Kawasaki disease; leaves open its role in coronary lesions.
Summary Kawasaki disease (KD) is an acute febrile syndrome of childhood, characterized by vasculitis of the medium-sized arteries. White blood cell counts and the inflammatory parameter C-reactive protein (CRP) are known to be elevated in the acute phase of the disease. In this study we investigated the course of inflammatory cell type-specific parameters in KD over a longer period of time. Plasma levels of human neutrophil elastase (HNE), matrix metalloproteinases-2 and -9 (MMP2, MMP9), and neutrophil gelatinase-associated lipocalin (NGAL), macrophage neopterin and CRP were measured. Plasma samples were collected in the acute, subacute and early convalescent stage, and three months after the onset of disease. Median CRP and neopterin normalized within two weeks. In contrast, six weeks and three months after onset of disease, levels of HNE were still elevated, with median values of 163 ng/ml and 156 ng/ml, respectively (control children median < 50 ng/ml; for all time-points P < 0·0001). Values of NGAL correlated with the levels of HNE (r = 0·39, P = 0·013). These results demonstrate a longer state of neutrophil activation in KD than was previously assumed. The potential relationship between this prolonged neutrophil activation, coronary artery lesion formation and their persistence, as well as the risk of premature atherosclerosis warrants further evaluation.
No takes yet. Share an insight, caveat, or question.
Biezeveld et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: